FDA Commissioner Marty Makary said that the agency can quickly track new drugs of pharmaceutical companies that “equally” the costs of pharmaceuticals between the United States and other countries, according to Bloomberg’s Rachel Cohrs Zhang and Sam Hornblower Report. In an interview with Wall Street Week in David Westin and Bloomberg Television, a company that promises the same price can receive a “national priority review voucher,” which can reduce the review time by 1-2 months. The Voucher said it is part of the new program announced by the FDA, and Makary said it could be used to incentive the company as an incentive to lower the drug price of other countries. Companies publicly traded in this universe include Astrazeneca.AZN) Bristol Myers (Bristol Myers)bmy), Eli Lilly (Lly), Gsk (GSK), Johnson & Johnson (JNJ), MERCK (MRK), Novartis (NVS), Pfizer (PFE), Roche (Roche) (Rhhby) And and Sanofi (chop).
First posted Thefly -Estimated source of financial news that moves in real time. Try now >>
See the hot stocks of insiders in tipranks >>
Learn more about JNJ.
